Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of changing the current standard of care in the future, DeepView® is expected to provide faster and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs.
Company Details
- Employees
- 82
- Address
- 2515 Mckinney Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.spectral-ai.com/
- HQ
- Dallas, TX
Spectral Ai Questions
Spectral Ai's website is http://www.spectral-ai.com/
Spectral Ai's LinkedIn profile is https://www.linkedin.com/company/spectralai
Spectral Ai has
82 employees.
View email and phone details for 82
employees at Spectral Ai.
Spectral Ai's industry is
Biotechnology Research
Spectral Ai's top competitors are
Mimedx,
Sanara Medtech,
Avita Medical,
Covalon Technologies Ltd.,
Osteal Therapeutics,
Argon Medical Devices, Inc.,
Abbott,
Sim Ip,
Alcon,
Biostem Technologies (Otc: Bsem).
Spectral Ai's categories are Biotechnology Research
